Professional Experience

25+ years of leadership in the biopharma industry

Worldwide VP, Cardiovascular, Metabolism & Pulmonary Hypertension

Johnson & Johnson Innovative Medicine

Basel, Switzerland•2021 – Present

Drove strategic oversight of $6B therapeutic portfolio, aligning clinical and commercial strategy with focus on US market. Partnered cross-functionally with R&D to prioritize market shaping and lifecycle strategy. Led campus relocation effort (500+ employees). Executive sponsor for women's leadership in EMEA.

Key achievements:

•Managed $6B therapeutic portfolio
•Led campus relocation (500+ employees)
•Executive sponsor women's leadership EMEA

VP & Managing Director

Janssen France (Johnson & Johnson)

Paris, France•2015 – 2021

Directed affiliate transformation into French market leader (>$1B turnover). Launched multiple therapies, delivering 30% growth in oncology. Founded "AI for Health" with Artefact, France's benchmark event in AI-health convergence. Appointed by French government to lead national AI & Health strategy initiative.

Key achievements:

•French market leader (>$1B turnover)
•30% growth in oncology
•Founded "AI for Health"
•Government appointment AI & Health strategy

Founder & President

Harmonium Pharma

France, Italy, UK•2012 – 2014

Founded and scaled venture in diabetes care (medical devices, nutraceuticals, cosmetics). Built regulatory, quality and sales infrastructures, secured EU partnerships. Deployed retail distribution model through Italian pharmacies.

Key achievements:

•Created multi-country diabetes care venture
•Regulatory and quality infrastructure
•Retail distribution Italian pharmacies

VP, Country Lead & Head of Specialty Care

Pfizer France

Paris, France•2009 – 2012

Oversaw €2B revenue and 3000 employees across 6 business units. Successfully led Wyeth integration, ensuring continuity and performance. Represented pharma industry in government and media during Mediator crisis.

Key achievements:

•Managed €2B revenue, 3000 employees
•Successful Wyeth integration
•Industry spokesperson Mediator crisis

VP & General Manager

Wyeth Pharmaceuticals France

Paris, France•2000 – 2009

Advanced from product management to business unit leadership and country GM. Delivered strong revenue performance across rheumatology and dermatology franchises. Key architect of affiliate growth leading to acquisition by Pfizer.

Key achievements: